JANX News and Press, Janux Therapeutics Inc. From 03/20/24

2024-03-20 12:21:57 ET More on Janux Therapeutics Janux Therapeutics: Yes There's New Data; No It's Not A Buy Here Trial Data Triggers Massive Rally In Janux Therapeutics Janux: Additional Opportunity With JANX007 Dosing Update In The 2nd Half Of 2024 Janux T...

2024-03-15 10:53:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Janux Therapeutics (NASDAQ: JANX ) just reported results for the fourth quarter of 2023. Janux Therapeutics reported earnings per share of -25 cents. This was above the an...

2024-03-15 09:45:00 ET Finding stocks that can triple in two years is hard enough. Finding those that can do so in a mere two months is that much more impressive. That's precisely what Viking Therapeutics (NASDAQ: VKTX) and Janux Therapeutics (NASDAQ: JANX) have accomplished...

2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

2024-03-08 16:06:21 ET More on Janux Therapeutics Janux Therapeutics: Yes There's New Data; No It's Not A Buy Here Trial Data Triggers Massive Rally In Janux Therapeutics Janux: Additional Opportunity With JANX007 Dosing Update In The 2nd Half Of 2024 Janux T...

Recently presented positive Phase 1 clinical trial data for PSMA-TRACTr JANX007 in mCRPC and for EGFR-TRACTr JANX008 in solid tumors Enrollment ongoing for JANX007 and JANX008 Update on JANX007 data and doses selected for expansion cohorts is anticipated in 2H 2024 $344.0 ...

Genesco Inc. (GCO) is expected to report $2.66 for Q4 2024 Broadway Financial Corporation (BYFC) is expected to report for quarter end 2023-12-31 Oji Holdings Corporation ADR (OJIPY) is expected to report for Q3 2024 Hibbett Inc. (HIBB) is expected to report $2.54 for Q4 2024 GRI ...

2024-03-06 11:25:10 ET Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market aver...

2024-03-03 01:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-02 06:56:00 ET With shares of Janux Therapeutics (NASDAQ: JANX) exploding upward to a high of more than 222% above its prior closing price on Feb. 27, it is no great shock that many investors are wondering whether the stock is still worth buying. The market is interpreting t...